Hypoglycaemic activity of Bauhinia holophylla through GSK3-β inhibition and glycogenesis activation

• Egile Nagusiak: Nathalia Ap. De Paula Camaforte (Egilea), Luiz Leonardo Saldanha (Egilea), Priscilla Maria Ponce Vareda (Egilea), João M. Rezende-Neto (Egilea), Mario R. Senger (Egilea), Aislan Q. Delgado (Egilea), Henrique J. N. Morgan (Egilea), Natalia Moretti Violato (Egilea), Laís Goyos Pieroni (Egilea), Anne Lígia Dokkedal (Egilea), Floriano P. Silva-Júnior (Egilea), José Roberto Bosqueiro (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2019-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Context: Bauhinia L. species, including Bauhinia holophylla (Bong.) Steud. (Fabaceae), have traditionally been used to treat diabetes. Bauhinia is a complex botanical genus, and the indiscriminate use of the diverse Bauhinia species is reflected in the experimental divergence of their medicinal pote...